PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of thoraxThoraxVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Thorax. 1996 June; 51(6): 564–568.
PMCID: PMC1090483

Age and the treatment of lung cancer.

Abstract

BACKGROUND: The average age of patients with lung cancer is increasing and there are large numbers of elderly symptomatic patients with this common disease. However, there are few data on how the treatment of this group differs from that of younger patients. METHODS: From 1 January 1990 information was collected for the Southend Lung Cancer Registry on all patients with a diagnosis of lung cancer in a geographically well defined health district of the UK with a population of 325,000. Every effort was made to find new cases from all departments of the hospital, including all clinical diagnoses, histopathological and cytological reports, and necropsies. All death certificates in the district were examined, irrespective of age, for any diagnosis of lung cancer. This therefore included any patient not seen by the hospital services. The differences in initial treatment have been analysed for three age groups: under 65, 65-74 years, and over 75. RESULTS: The 563 cases of lung cancer diagnosed during a 30 month period were included in the study, of whom 240 (43%) were aged over 75 years. The overall mean age was 71 years (range 31-95). The incidence of lung cancer in the general population was 69 per 100,000, but in men over 75 years of age it rose to 751 per 100,000. For all patients the active treatment rate (chemotherapy, surgery, or radiotherapy) was 49%, but for patients not reviewed by a chest physician (n = 86) it was only 21%. There were large differences in initial treatment between age groups. For patients with non-small cell lung cancer (NSCLC) reviewed by a chest physician, surgery was undertaken in 18% of those under 65, 12% of the 65-74 age group, and 2.1% of those over 75. For patients with small cell lung cancer (SCLC) reviewed by a chest physician, 79% of those aged under 65, 64% of the 65-74 age group, and 41% of patients aged over 75 received chemotherapy. In patients with NSCLC reviewed by a chest physician, chemotherapy was given to 21% under 65, 6.4% in the 65-74 age group, and none over 75. If no histological diagnosis was made 37% of patients aged under 75 and only 5.4% of those over 75 received either surgery, radiotherapy, or chemotherapy. Patients not reviewed by a chest physician were less likely to have had a histological diagnosis. Differences in treatment rates with age persisted even after allowing for performance score status at presentation. CONCLUSIONS: Lung cancer is a common disease in the elderly and, in our district, 43% of patients were aged 75 or over at presentation. Age alone appeared to be a major factor in influencing treatment choices, and treatment was more likely if histological confirmation was obtained. Further detailed analysis of the reasons for the differences is needed. Patients referred to chest physicians were more likely to have both histological confirmation and active treatment. This study supports the contention that all patients with a diagnosis of lung cancer, irrespective of age or condition, should be assessed by an accredited chest physician.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (914K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lee-Chiong TL, Jr, Matthay RA. Lung cancer in the elderly patient. Clin Chest Med. 1993 Sep;14(3):453–478. [PubMed]
  • Le Roux BT. Bronchial carcinoma. Thorax. 1968 Mar;23(2):136–143. [PMC free article] [PubMed]
  • Davis DL, Lilienfeld AD, Gittelsohn A, Scheckenbach ME. Increasing trends in some cancers in older Americans: fact or artifact? Toxicol Ind Health. 1986 Jul;2(1):127–144. [PubMed]
  • Connolly CK, Jones WG, Thorogood J, Head C, Muers MF. Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983. Br J Cancer. 1990 Apr;61(4):579–583. [PubMed]
  • Muers MF, Round CE. Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax. 1993 Apr;48(4):339–343. [PMC free article] [PubMed]
  • Patients presenting with lung cancer in south east Scotland. Edinburgh Lung Cancer Group. Thorax. 1987 Nov;42(11):853–857. [PMC free article] [PubMed]
  • Mañ JM, Estapé J, Sánchez-Lloret J, Grau JJ, Palombo H, Agusti C, Mellado B. Age and clinical characteristics of 1433 patients with lung cancer. Age Ageing. 1994 Jan;23(1):28–31. [PubMed]
  • O'Rourke MA, Feussner JR, Feigl P, Laszlo J. Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly. JAMA. 1987 Aug 21;258(7):921–926. [PubMed]
  • DeMaria LC, Jr, Cohen HJ. Characteristics of lung cancer in elderly patients. J Gerontol. 1987 Sep;42(5):540–545. [PubMed]
  • Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS, Fretwell MD. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc. 1985 Sep;33(9):585–589. [PubMed]
  • Battle RM, Pathak D, Humble CG, Key CR, Vanatta PR, Hill RB, Anderson RE. Factors influencing discrepancies between premortem and postmortem diagnoses. JAMA. 1987 Jul 17;258(3):339–344. [PubMed]
  • Watkin SW, Hayhurst GK, Green JA. Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86. Br J Cancer. 1990 Apr;61(4):590–596. [PubMed]
  • Wetle T. Age as a risk factor for inadequate treatment. JAMA. 1987 Jul 24;258(4):516–516. [PubMed]
  • Fentiman IS, Tirelli U, Monfardini S, Schneider M, Festen J, Cognetti F, Aapro MS. Cancer in the elderly: why so badly treated? Lancet. 1990 Apr 28;335(8696):1020–1022. [PubMed]
  • Hunt RW. A critique of using age to ration health care. J Med Ethics. 1993 Mar;19(1):19–27. [PMC free article] [PubMed]
  • Brancati FL, Chow JW, Wagener MM, Vacarello SJ, Yu VL. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet. 1993 Jul 3;342(8862):30–33. [PubMed]
  • Chelluri L, Pinsky MR, Donahoe MP, Grenvik A. Long-term outcome of critically ill elderly patients requiring intensive care. JAMA. 1993 Jun 23;269(24):3119–3123. [PubMed]
  • Begg CB, Cohen JL, Ellerton J. Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group. Cancer Clin Trials. 1980;3(4):369–374. [PubMed]
  • Smit EF, Carney DN, Harford P, Sleijfer DT, Postmus PE. A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax. 1989 Aug;44(8):631–633. [PMC free article] [PubMed]
  • Evans EW. Resection for bronchial carcinoma in the elderly. Thorax. 1973 Jan;28(1):86–88. [PMC free article] [PubMed]
  • Shirakusa T, Tsutsui M, Iriki N, Matsuba K, Saito T, Minoda S, Iwasaki T, Hirota N, Kuono J. Results of resection for bronchogenic carcinoma in patients over the age of 80. Thorax. 1989 Mar;44(3):189–191. [PMC free article] [PubMed]

Articles from Thorax are provided here courtesy of BMJ Group